Nissui Corporation1332.T

The interesting thing about Nissui is not the record, it is what the record is made of. FY March 2026 printed ¥40.4bn of operating profit, up 27%, and the market re-rated the share from 0.78x book at the 2023 trough to 1.29x today, filing the print under "structural upgrade" and pointing to the aquaculture pivot as the proof. The question the dossier turns on is whether that record is the start of a durable improvement in the return on capital, or a cyclical and currency-flattered peak that the share price has already paid for.

The distinction matters because the rebound is unusually narrow. Marine Products operating profit doubled in one year, from ¥8.4bn to ¥17.8bn, and that single segment sits near the top of a decade range that has swung between ¥8.4bn and ¥18.6bn without a trend. Strip the FX translation and the Marine cycle back to mid-cycle and roughly ¥8bn of the record is non-recurring — the normalised operating profit is about ¥32.5bn, a fifth below the reported line. The consolidated margin is rising, but it is rising on a narrow and cyclical base.

The second point is the one the market is ignoring. Return on capital fell, from 6.1% to 5.9%, in the year of the record — because the capital base swelled faster than the profit it generated. A ¥20.5bn acquisition (PESQUERA YADRAN, Chilean salmon), a ¥43.1bn capex year at 1.62x depreciation, and ¥29.3bn into working capital outran the ¥8.7bn of incremental operating profit. Return on capital has not durably cleared the cost of capital in ten years, sitting in a 4.2–6.1% band ; while it stays below the hurdle, each yen deployed into the pivot is at best value-neutral, whatever the margin looks like.

The dossier was inherited as an exporter trap — a uniform currency illusion, ~52% of operating profit earned overseas on a weak yen. Read against the cellular geography, that premise is half right. The Marine overseas leg, Chile especially, is cyclical and FX-driven. But the Food overseas leg is structurally real: its segment operating profit tripled over the decade, from ¥4.3bn to ¥14.2bn, on volume and share in North America and Europe, not on translation. Two pockets are genuinely under-priced — that structural Food leg and the under-monetised cold-chain at a 14.5% margin — and they sit beneath a Marine-and-FX over-extrapolation and a balance sheet re-levered to finance an unproven bet.

The position framing is observation, not ownership at this level. The weighted asymmetry is about −30% and even the bull case offers only +8%, so there is no margin of safety in the price. It is not a short either: the downside is a reversible FX-and-cycle disappointment rather than a permanent impairment, the timing of a short is exposed to a yen that can stay weak for a long time, and the aquaculture optionality is real if unproven. Conviction is moderate. The things worth watching are the aquaculture return and the Marine print, both observable on the published calendar.

The cleanest way to read the last decade is as three regimes. Nissui entered it deleveraging out of an over-borrowed balance sheet, gross margin still near 21% and operating margin around 3%. The COVID and commodity-inflation years reset the gross margin below 16% and drove the share under book — to 0.78x at the FY March 2023 trough, where the market was signalling that deployed capital was worth less than its carrying value. The GOOD FOODS regime since has produced the record prints, the re-rating to 1.29x book, and the debt-financed aquaculture pivot. The shape matters because it makes any valuation anchored on a ten-year average multiple misleading — that average spans a sub-book trough and a re-rated peak.

Two readings come out of the table. EBIT roughly doubled, from ¥19.4bn to ¥40.4bn, but return on capital never durably cleared the cost of capital — it sat in a 4.2–6.1% band and fell at the very year of the record. Return on equity declined over the decade, from 13.3% to 9.5%, as financial leverage came down faster than asset productivity improved. Earnings per share rose mostly on nominal profit growth rather than on any compounding of returns, and the re-rating of book tracks the record print, not a proven upgrade.

The decisive financial decision of the decade is the balance sheet. Nissui deleveraged patiently, from 6.2x net debt to EBITDA down to 3.5x — and then re-levered to 3.7x in a single year to fund the YADRAN acquisition and the capex bond, at the conjoint peak of the Marine cycle and the weak yen. The guidance already prices the cost: FY March 2027 ordinary profit is guided down 0.4% despite operating profit up 5.1%, on higher interest expense from the growth investments. The leverage eats the operating growth one line down.

The engine only makes sense once you stop reading the consolidated line and read segment by geography, because a single 4.34% group margin is the average of three economically different businesses. The cellular maille shows a structurally growing Food overseas leg, a violently cyclical Marine business, and an under-monetised cold-chain. Food Products earns 5.9% on ¥501bn of revenue and its overseas profit tripled over ten years to ¥14.2bn ; Marine earns 4.7% on ¥380bn but its segment profit has swung 2x in two years ; General Distribution earns 14.5%, the most profitable line in the group, on cold-chain infrastructure ; and Fine Chemicals, once framed as the premium optionality, has eroded to ¥0.8bn from ¥4.6bn a decade ago.

Where the pricing power actually lives is the question the consolidated margin buries. Gross margin fell 4.5 points over the decade while selling prices rose — the proof that there is no structural pricing power on the commoditised core. What the market reads as Marine "pricing" is a landing-price windfall on strong catches, not value pricing ; the Japan Food price increase even cost volume, which is why FY March 2027 Food operating profit is guided down 6.2% on the pass-through lag. The only genuine pricing sits in the branded transformed layer — surimi, fish sausage — and in the cold-chain, where the logistics shortage gives real leverage.

The cost that drives most of the margin volatility is the marine input spread — fish landings, fleet fuel and aquaculture feed, all amplified by the currency. It is exogenous, spot-priced and passes through with a roughly three-month lag on a 98-day inventory, so the published margin lags the real economic cost at every turn in the cycle. Nissui manages this by integrating upstream, owning the fleet, the farms and the licences, which partly hedges the input but does not neutralise it — and the operational risk is borne entirely by the integrator, the archetype in which it is least transferable.

The cash bridge is structurally weak, and that is part of what makes the record hollow. Free cash flow converted at about 29% of EBIT over five years and only ~25% in the record year — ¥10.2bn of FCF on ¥40.4bn of EBIT — because the capex, the YADRAN deal and ¥29.3bn of working capital absorbed the cash. The marine working-capital cycle, at 111 days, decouples margin from cash structurally, and the aquaculture pivot consumes cash upstream, in fish work-in-process and feed, long before it returns any. The record operating profit did not become cash.